Immunoglobulin heavy variable region 2-1 (IGHV2-1)

The **immunoglobulin heavy variable region 2-1** is proposed as a gene segment associated with the variable domain of the immunoglobulin heavy chain, forming part of the antigen-binding pocket of antibody molecules produced by B lymphocytes. However, the designation “IGHVIII-2-1” is not an accepted gene symbol or protein name in molecular immunology. Human IGHV genes encode variable regions used by B cells to generate antibody diversity via recombination. The IGHV gene family exhibits extensive polymorphism, contributing to individual differences in immunity and disease susceptibility. Some IGHV alleles and usage patterns serve as biomarkers in hematological malignancies and autoimmunity but are not considered direct therapeutic targets; rather, the antibodies encoded by these segments may become drugs or diagnostics[1][2][3][4][5]. Summary of Key Issues: - "IGHVIII-2-1" is not a canonical gene; it may reflect non-standard, erroneous, or legacy nomenclature, or refer to a pseudogene. - Correct IGHV gene names are formatted as "IGHV#-#" (e.g., IGHV3-21), not "IGHVIII-2-1". - Individual IGHV variable regions are not direct drug targets. - No drugs, mechanisms of action, or safety issues are directly linked to this segment. - IGHV alleles (as a family) are molecular biomarkers and have roles in antibody diversity, disease susceptibility, and pharmacogenomic studies[2][4][5]. If you need a report for a canonical immunoglobulin variable heavy chain gene (e.g., IGHV1-2, IGHV3-21), further clarification or correction of the target name is advised.

Other names

IGHVIII-2-1IGHV(III)-2-13-02.1PIGHVIII21

Not applicable for drugs; biologically, participates in antigen recognition, triggers immune response.